Positive and negative regulation of IL-2 gene expression: role of multiple regulatory sites

Cytokine. 1994 May;6(3):221-8. doi: 10.1016/1043-4666(94)90016-7.

Abstract

Interleukin 2 (IL-2) is an important lymphokine required in the process of T cell activation, proliferation, clonal expansion and differentiation. The IL-2 gene displays both T cell specific and inducible expression: it is only expressed in CD4+ T cells after antigenic or mitogenic stimulation. Several cis-acting regulatory sites are required for induction of the IL-2 gene after stimulation. In this study, we have analysed the function of these cis-acting regulatory sites in the context of the native IL-2 enhancer and promoter sequence. The results of this study suggest that the NFAT (-276 to -261), the distal octamer (-256 to -248) and the proximal octamer (-75 to -66) sites not only act as enhancers of IL-2 gene transcription in the presence of cellular stimulation, but also have a silencing effect on IL-2 gene expression in resting cells. Two other sites display disparate effects on IL-2 gene expression in different T leukemia cell lines: the distal purine box (-291 to -277) and the proximal purine box sites (-145 to -128). Finally, the AP-1 (-186 to -176) and the kappa B sites (-206 to -195) respond to different cellular activation in EL4 cells. The AP-1 site mediated the response to PMA stimulation while the kappa B site responded to IL-1 stimulation. These data suggest that the regulation of IL-2 gene expression is a complex process and multiple cis-acting regulatory sites interact to exert different effects in T cells representative of alternative stages of differentiation.

MeSH terms

  • Animals
  • Base Sequence
  • Binding Sites
  • Cell Line
  • Chloramphenicol O-Acetyltransferase / biosynthesis
  • Enhancer Elements, Genetic*
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Interleukin-1 / pharmacology
  • Interleukin-2 / biosynthesis*
  • Interleukin-2 / genetics
  • Ionomycin / pharmacology
  • Leukemia, T-Cell
  • Lymphocyte Activation
  • Molecular Sequence Data
  • Mutagenesis, Site-Directed
  • NF-kappa B / metabolism
  • Oligodeoxyribonucleotides
  • Plasmids
  • Promoter Regions, Genetic*
  • Proto-Oncogene Proteins c-jun / metabolism
  • Purines
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / immunology*
  • T-Lymphocytes / metabolism
  • TATA Box
  • Transcription Factors / metabolism*
  • Transcription, Genetic / drug effects
  • Tumor Cells, Cultured

Substances

  • Interleukin-1
  • Interleukin-2
  • NF-kappa B
  • Oligodeoxyribonucleotides
  • Proto-Oncogene Proteins c-jun
  • Purines
  • Transcription Factors
  • Ionomycin
  • Chloramphenicol O-Acetyltransferase